INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined grapes. Clear

An expert overview of the literature, useful as background reading.

8 studies

2019 / Comprehensive narrative review

Plant-based diets and polyphenol-rich plant foods show emerging evidence for supporting cognitive function and preventing age-related cognitive decline.

This review examined human studies on plant-based dietary patterns and polyphenol-rich foods regarding age-related cognitive decline and cognitive function. Currently, direct evidence supporting vegetarian diets for preventing cognitive decline is lacking. However, emerging evidence supports plant-based patterns like the Mediterranean diet, and randomized clinical trials support plant foods such as citrus fruits, grapes, berries, cocoa, nuts, green tea, and coffee in improving specific cognitive domains, notably frontal executive function.

Rajaram S, Jones J, Lee GJ Adv Nutr, 2019. PMID 31728502

2015 / Narrative review

Evidence shows inconsistent and contrasting findings regarding red wine's potential benefits against postprandial stress.

This review examined available evidence on the effects of red wine on postprandial-induced metabolic and oxidative stress in humans. Following red wine consumption with a meal, non-enzymatic antioxidant capacity and lipoperoxidation markers improved, but confounding factors like increases in uric acid must be considered. Furthermore, ethanol-induced increases in both uric acid and triglycerides could cause liver damage. The authors concluded that inconsistent and contrasting findings exist regarding the benefits of red wine on postprandial stress.

Peluso I, Manafikhi H, Reggi R, et al. Eur J Nutr, 2015. PMID 25772634

2013 / Narrative review

Evidence linking phytonutrients like lycopene and polyphenols to bone health is currently insufficient for precise dietary recommendations.

This review evaluates evidence regarding commonly consumed phytonutrients—including lycopene and polyphenols from tea, grape seed, citrus fruit, olive, and dried plum—and their role in bone health during aging. Current evidence remains insufficient to establish clear links or generate precise dietary recommendations due to mixed findings and scarce clinical data. Future clinical trials evaluating determinants of bone strength, as well as combinations with calcium and vitamin D, are needed.

Sacco SM, Horcajada MN, Offord E Br J Clin Pharmacol, 2013. PMID 23384080

2012 / Editorial / commentary on a randomized phase II trial

A commentary reports that 60 g/day of strawberry powder reduced the histologic grade of dysplastic lesions in an esophageal cancer prevention trial.

This commentary discusses a randomized noncomparative phase II trial in China testing two doses of strawberry powder (60 g/d or 30 g/d for six months) to prevent esophageal cancer. The 60 g/d dose reduced the histologic grade of dysplastic lesions and reduced localized biomarkers, whereas the 30 g/d dose was not effective. The author notes that fundamental questions remain regarding formulation, active components, and mechanisms of action.

Suh N, Pezzuto JM Cancer Prev Res (Phila), 2012. PMID 22219164

2012 / Narrative review

Plant polyphenols, including grape and blueberry juices, show potential in the treatment of cognitive impairment in preliminary human trials and rodent studies.

This review discusses the potential role of plant polyphenols and fruit products in treating age-related cognitive disorders and dementia. Blueberry, strawberry, blackberry, grape, and plum juices or extracts have been tested in cognitively impaired rodents, and small human trials have examined grape and blueberry juice. Specific polyphenols like resveratrol and pterostilbene have been studied or shown to improve cognition in rodents. Future human trials need to consider poor bioavailability, optimal timing of therapy, and the appropriate form of treatment.

Cherniack EP Br J Nutr, 2012. PMID 22475317

2012 / Narrative review

A review highlights evidence that fruits like dried plum and citrus, along with their phytochemicals, support bone protection and microarchitecture.

This review evaluated animal and cellular studies of dried plum, citrus, berry fruits, and bioactive compounds (lycopene, phenolics, flavonoids, resveratrol, phloridzin, and pectin) alongside human studies of dried plum and lycopene. Cross-sectional studies show a positive association between higher fruit intake and higher bone mineral density. Animal studies suggest antioxidant-rich fruits promote higher bone mass and strength by enhancing bone formation and suppressing resorption through antioxidant or anti-inflammatory pathways.

Shen CL, von Bergen V, Chyu MC, et al. Nutr Res, 2012. PMID 23244535

2011 / Literature review

Evidence suggests a subgroup of children with ADHD experience symptom changes linked to artificial food colors and specific foods.

This review examined 35 years of research on dietary sensitivities and ADHD symptoms. In children with suspected sensitivities, 65% to 89% reacted when challenged with at least 100 mg of artificial food colors (AFCs). Oligoantigenic diet studies indicated that some children sensitive to AFCs also react to common foods (milk, chocolate, soy, eggs, wheat, corn, legumes) as well as grapes, tomatoes, and orange. Additionally, 2 large studies demonstrated behavioral sensitivity to AFCs and benzoate in children both with and without ADHD.

Stevens LJ, Kuczek T, Burgess JR, et al. Clin Pediatr (Phila), 2011. PMID 21127082

2011 / Narrative review

A review summarizes human pharmacokinetic and pharmacodynamic data for resveratrol, noting a lack of clinical evidence and conflicting capsule versus food data.

This review examines nutrapharmacology and the therapeutic potential of resveratrol, a polyphenol found in grape skins and other plants, for targeting aging and obesity-related chronic diseases. It evaluates laboratory findings on inflammation and oxidative stress alongside published human pharmacokinetic and pharmacodynamic data. The authors note key obstacles to clinical use, including a lack of clinical evidence to date, a myriad of available doses and formulations, conflicting data on capsules versus food forms, and uncertain effects of long-term dosing.

Chachay VS, Kirkpatrick CM, Hickman IJ, et al. Br J Clin Pharmacol, 2011. PMID 21410504